Oral estrogen undergoes first-pass metabolism in the liver, which can increase clotting factors and elevate the risk of venous thromboembolism
ZSP1601 suppresses inflammatory responses in MASH, with its maximum inhibitory effect occurring on PDE2 as shown by both in vitro and in vivo studies
One syringe (typically 1 mL to 3 mL) is used to draw the BAC water and inject it into the peptide vial
Orlistat, phentermine/topiramate, naltrexone/bupropion, and the incretin-based drugs liraglutide and semaglutide, both GLP-1 receptor agonists (GLP-1RA), and tirzepatide, a biased dual GIP/GLP-1 receptor agonist, are currently both FDA and EMA approved for the management of non-syndromic obesity 10
(August 2025)
This is the origin of the widely repeated claim that BPC-157 is "remarkably safe." However, several important caveats apply